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Anaerobic infections usually occur when an anatomical
barrier becomes disrupted and constituents of the local
flora enter a site that was previously sterile. Any site in the
body is susceptible to infection with these indigenous
organisms when a mucosal barrier or the skin is compro-
mised by surgery, trauma, tumor, ischemia, or necrosis,
all of which can reduce local tissue redox potentials [1].
Despite the relatively low incidence of anaerobic infection
and decreased percentage among positive blood cultures,
it remains associated with significant mortality [2]. 
There have been only a few studies in Korea about
anaerobic pathogens, and these have had either a short
study duration and limited information or number of cases
[3,4]. Recently Park et al. reported the clinical features of
anaerobic infections and defined the factors inde-
pendently associated with mortality during 7 yr in a single
university affiliated hospital [5]. Although these data had
several limitations, they provided some very important
information, such as clinical manifestations, frequent
pathogens, mortality, and associated prognostic factors of
anaerobic infections with the relatively large sample size
examined. 
They reported that the most common anaerobes by rank
were Bacteroides fragilis,Clostridium spp., Prevotella spp.,
and Peptostreptococcus spp.  However, when the anaerobes
were combined according to genus, Peptostreptococcus
spp. were the second most common organisms. It was also
stated that there were no anaerobes isolated from the
central nervous system and/or bone and joint infections.
For example, central nervous system infections associated
with anaerobic bacteria are brain abscess, epidural ab-
scess, and subdural empyema. If optimal bacteriologic
techniques are employed, it is reported that as many as
85% of brain abscesses yield anaerobic bacteria, which
usually originate from an otolaryngeal infection [1]. 
Successful therapy for anaerobic infections requires the
administration of a combination of appropriate antibiotics,
surgical resection, debridement of devitalized tissues, and
drainage either by surgery or percutaneously [6]. In this
article, there was no correlation between surgical approach
and mortality. A surgical procedure may be an adjunct to
a medical treatment. In addition, drainage of pleuropul-
monary abscesses, except empyema, is usually contrain-
dicated because the abscesses may spread to other lung
tissues during the procedure [6]. There are many con-
founding factors for analyzing the prognosis in these cases
and that is why a prospective study is needed. 
The outcome of anaerobic bacteremia is known to be
significantly better in patients either initially given or
switched to appropriate therapy based on known anti-
biotic susceptibilities [7]. When we try to define the
appropriateness of antibiotic prescription for anaerobic
infections, there are several factors to be considered. 1)
Growing resistance pattern, for example, increasing
resistance to metronidazole among gram-positive anae-
robes and clindamycin resistance among isolates of the B.
fragilis group [7]. There have been anecdotal reports that
cefoxitin and cefotetan were discouraged as first line
therapy for intra-abdominal infections [8]. Antibiotic
resistance among anaerobes continues to rise, which is not
surprising given the parallel observations among aerobes
over the last several decades. 2) Switching initial empirical
therapy to susceptible antibiotics after culture reports [7].
3) Including antibiotics active against other gram-negative
or positive facultative aerobes for treating mixed infections,
especially in case of intra-abdominal sepsis [2,6]. In this
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See Article on Page 13-18article, although they defined the appropriate/inappropriate
coverage of antibiotics, further detailed definition in the
future would be needed. We should also focus on the new
antibiotics (tigecycline and newer fluoroquinolones) that
are known to be active against mixed aerobic-anaerobic
infections [7]. Antimicrobial susceptibility testing of
anaerobes is still rarely performed at most hospitals.
Current and future adoption of the standardized method
will allow better comparisons among studies, as well as
susceptibility results that physicians could rely on with
the same practice as for aerobes testing results [7]. 
Park et al. found that age and liver disease were strong,
independent risk factors for mortality in a multivariate
analysis, and the data demonstrated a 29.7% crude
mortality for clinically significant anaerobic infections.
Previous studies reported similar rates (25-44%) and risk
factors [2]. Differences in clinical significance according to
specific anaerobic pathogens will be elucidated in the
future.
In conclusion, Park et al. demonstrated that the majority
of patients infected with anaerobes had a polymicrobial
infection and that mortality of anaerobic infections still
remained high in the era of effective antibacterial therapy.
They have also demonstrated the association between
liver disease, old age and mortality. Further well designed
prospective studies are warranted to confirm these asso-
ciations and to determine the relationship between clinical
failure and different species and/or resistant anaerobic
pathogens. (Korean J Intern Med 2009;24:11-12)
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